Diaceutics PLC announced revenue results for the six months ended 30 June 2023. For the period, the company reported revenue grew 32% to £9.9 million in against £7.5 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
133.4 GBX | +0.68% | +0.30% | +53.33% |
May. 28 | Sirius Real Estate Non-Exec Director James Peggie to resign | AN |
May. 24 | Michael Ashcroft ups stake in Marlowe to 16% | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.33% | 143M | |
+11.94% | 4.29B | |
-20.55% | 2.3B | |
+30.36% | 1.94B | |
-7.98% | 1.44B | |
-10.73% | 1.58B | |
-22.28% | 1.48B | |
-28.92% | 1.26B | |
-13.77% | 1.09B | |
-9.59% | 993M |
- Stock Market
- Equities
- DXRX Stock
- News Diaceutics PLC
- Diaceutics PLC Announces Revenue Results for the Six Months Ended 30 June 2023